4//SEC Filing
Nabriva Therapeutics Plc 4
Accession 0001104659-17-043682
CIK 0001703287other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 8:15 PM ET
Size
5.5 KB
Accession
0001104659-17-043682
Insider Transaction Report
Form 4
Crotty Robert
General Counsel & Corp Secreta
Transactions
- Award
Stock Option
2017-06-30+90,000→ 90,000 totalExp: 2027-06-30→ Ordinary Shares (90,000 underlying)
Footnotes (2)
- [F1]The exercise price is $10.48 per share.
- [F2]This option was granted on June 30, 2017. Vesting will begin on June 30, 2017 and end on June 30, 2021. Twenty-five percent (25%) of the option will vest on June 30, 2018, and the remaining seventy-five percent (75%) will vest on a monthly pro-rata basis over the remaining vesting period.
Documents
Issuer
Nabriva Therapeutics Plc
CIK 0001703287
Entity typeother
IncorporatedIreland
Related Parties
1- filerCIK 0001703287
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 8:15 PM ET
- Size
- 5.5 KB